3 Drug Stocks to Buy at a Discount [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Novo Nordisk just got approval for a GLP-1 pill, which could again upend the dynamics for weight loss drugs. This is just how the pharmaceutical sector operates, and it is why you might want to consider Bristol Myers Squibb, Merck, and Pfizer. 10 stocks we like better than Bristol Myers Squibb › The pharmaceutical industry is highly technical, and significant developments can rapidly transform the sector. For instance, Novo Nordisk 's (NYSE: NVO) introduction of GLP-1 weight loss drugs was a huge development. Eli Lilly (NYSE: LLY) introduced more attractive GLP-1 drugs, however, leading to Novo Nordisk losing its early lead in the weight loss niche. More change is on the way, including from Novo Nordisk, but if you have a contrarian bent, you might prefer out-of-favor drug makers Bristol Myers Squibb (NYSE: BMY) Merck (NYSE: MRK) , and Pfizer (NYSE: PFE) Novo Nordisk kick-started the GLP-1 market in a big way. Eli Lilly entered the market with GLP-1 shots that were more att
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk reportedly cut Wegovy prices in China by half [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk (NVO) Gets 9% Boost from Wegovy Pill OK [Yahoo! Finance]Yahoo! Finance
- The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA. [Yahoo! Finance]Yahoo! Finance
- Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (Rating Upgrade) [Seeking Alpha]Seeking Alpha
- Novo Nordisk just pulled off something nobody saw coming [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website